Vimarsana
Biggest News Aggregation in the World

Page 4 - Filing Deadline News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Filing Deadline. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Filing Deadline Today - Breaking & Trending Today

SPoT Coffee Announces Delayed Filing of Annual Financial Statements and Application for Management Cease Trade Order - Vimarsana News

SPoT Coffee Announces Delayed Filing of Annual Financial Statements and Application for Management Cease Trade Order

SPOT COFFEE LTD. provides an update on the status of the filing of its audited annual financial statements, accompanying management discussion and analysis and related CEO and CFO certifications in...

StageZero Life Sciences Provides an Update on Application for Management ... - Vimarsana News

StageZero Life Sciences Provides an Update on Application for Management ...

StageZero Life Sciences Provides an Update on Application for Management ...

Christina Lake Cannabis Announces Delay in Filing its 2023 - Vimarsana News

Christina Lake Cannabis Announces Delay in Filing its 2023

VANCOUVER, British Columbia, April 03, 2024 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. (

Mistrial declared in Dr. Scott Lynch's case against Penn State - Vimarsana News

Mistrial declared in Dr. Scott Lynch's case against Penn State

A mistrial was declared during opening arguments for an orthopedic surgeon's lawsuit against Pittsburgh, Pa.-based Penn State, CBS News reported March 11.

Intellipharmaceutics Announces Its Expected Delay in Filing Annual Audited Financial Statements and - Vimarsana News

Intellipharmaceutics Announces Its Expected Delay in Filing Annual Audited Financial Statements and

TORONTO, ON / ACCESSWIRE / February 26, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release...